Physicians' Academy for Cardiovascular Education

Which patients with CKD and diabetes will benefit from management with GLP-1RA?

Listen to the podcast
10' education - June 13, 2022 - Prof. Katherine Tuttle, MD - Spokane, WA, USA

Video navigation menu

  • Kidney outcomes with GLP-1RA in CVOTs with T2DM patients 2:35
  • Biological plausibility of effects of GLP-1RAs 7:01
  • Use of GLP-1RA in clinical practice 8:35
  • Multidisciplinary team care for patients with T2DM and CKD 9:14
  • Casus presentation and discussion 9:54


Show transcript

Educational information

This lecture by Katherine Tuttle was part of the EBAC-accredited symposium "Preventing CKD in patients with diabetes - Exploring the current and future role of GLP-1RA" held during the ERA 2022 congress.


Katherine Tuttle is Clinical Professor of Medicine, Nephrology, University of Washington at Spokane, WA, USA.


This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

This educational activity is intended for an international audience of non-US and non-UK HCPs


Funding for this educational program was provided by an unrestricted educational grant from Novo Nordisk A/S.

Click here for the slides of this presentation

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: